ERBB2 and cancer: Initially, YBX1 was found to transcriptionally activate the expressions of ABCB1, an ATP-binding cassette transporter associated with multidrug resistance [27], as well as the growth factor receptor genes EGFR and HER2/ErbB2 in cancer cells [28–30].